CHARLESTON – Forty-eight attorneys general, led by West Virginia and New Mexico, have joined a coalition to seek information from the United States Food and Drug Administration on how to help fight the opioid crisis.
In a letter to FDA Commissioner Stephen Hahn, the group said it was seeking a report to find out what it was doing to combat opioid abuse, a power that Congress had given in 2018.
The attorneys general, led by attorneys general of West Virginia and New Mexico, Patrick Morrisey and Hector Balderas, believe the FDA is now playing an important role in ensuring the safety and efficiency of opioid prescribing and want to know how the FDA does it Strength begins.
“As the ultimate legal advisor to our states, we are committed to using all the tools we can to fight this epidemic and protect patients with chronic pain or addiction who are among the most vulnerable consumers in our society,” said Morrisey.
The coalition sees clarifications on how the FDA has used them and plans on how it will continue to use powers granted under the Substance Use Disorders Prevention Act to promote opioid recovery and treatment for patients and communities better known as SUPPORT Act, are provided.
The law should create safer features for the packaging and disposal of opioids, research and enact new regulations for non-addictive alternatives to opioids, and guidelines for prescribing opioids.
The letter addressed to FDA Commissioner Stephen Hahn alleged the information requested would help reduce prescription opioid abuse and deaths from overdose.
Morrisey said he co-led a similar call in 2017 for health insurers to review and revise their payment and coverage policies to prioritize non-opioid pain management options for chronic, non-cancer pain.